Because there are no identifiable symptoms or indications, most individuals are suspected of having NAFLD based on the inadvertent discovery of elevated serum alanine aminotransferase (ALT) and γ-glutamyl transpeptidase (GGT) levels or imaging data demonstrating diffuse fatty liver [9]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.